YieldTerminal Pro
Calculator
← Back to all articles

Articles · Market Video, Morning Watch

RKLB: Record Revenue, $3.57B Backlog and Neutron Timing

Rocket Lab reported record Q3 revenue and backlog after the November 9 close, while its first Neutron launch is targeted no earlier than 2027.

Published Nov 10, 2026

Watch on YouTube ↗

TL;DR

  • Q3 revenue was about $268 million, up 73% year over year, per Rocket Lab's SEC exhibit.
  • The company reported a record $3.57 billion backlog and targeted Neutron's first launch no earlier than 2027.
  • RKLB closed November 9 at $58.86, just above a $56.13–$58.41 YTP Zones support area.

Rocket Lab reported about $268 million of third-quarter revenue, up 73% from a year earlier, and a record $3.57 billion backlog after the November 9 close. Its release targets Neutron's first launch no earlier than 2027; that is a schedule, not a completed launch. Watch the RKLB Short.

Completed November 9 chart

RKLB closed the regular session at $58.86, up 10.91% from November 6. The attributed TradingView daily chart showed a YTP Zones support area at $56.13–$58.41 and next resistance at $63.40–$65.67. Its $62.45 50-day and $78.72 200-day averages remained above the close. Any later move needs a new completed session to assess; the chart does not imply a live price or guaranteed target.

TradingView daily chart through the completed November 9 regular session. Open full size to read dated levels; current premarket quotes are not plotted.Open chart to enlarge and pan at full size.

See the November 10 Daily Levels and Morning Map. Market research only, not a recommendation to buy or sell.

Source: Rocket Lab Q3 SEC earnings exhibit; TradingView daily chart with visible attribution.

Get the Sunday Recap by email

One email a week. Every issue is published on the site too, so this is only about getting it in your inbox.

Subscribing signs you up for the free YieldTerminal Sunday recap, one email a week. Educational only, not financial advice. Unsubscribe any time.

Educational commentary, not a recommendation to buy or sell anything.

Daily stock reviews · Daily movers

← Back to all articles

See the full disclaimer.